PH22999A - 3-cyano-5-(6-imidazo(1,2-a)pyridyl)-pyridin-2-ols useful as cardiotonics - Google Patents

3-cyano-5-(6-imidazo(1,2-a)pyridyl)-pyridin-2-ols useful as cardiotonics

Info

Publication number
PH22999A
PH22999A PH33568A PH33568A PH22999A PH 22999 A PH22999 A PH 22999A PH 33568 A PH33568 A PH 33568A PH 33568 A PH33568 A PH 33568A PH 22999 A PH22999 A PH 22999A
Authority
PH
Philippines
Prior art keywords
sup
group
hydrogen atom
represents hydrogen
lower alkyl
Prior art date
Application number
PH33568A
Other languages
English (en)
Inventor
Motosuke Yamanaka
Kazutoshi Miyake
Shinji Suda
Hideto Ohhara
Toshiaki Ogawa
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH22999A publication Critical patent/PH22999A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH33568A 1985-03-26 1986-03-24 3-cyano-5-(6-imidazo(1,2-a)pyridyl)-pyridin-2-ols useful as cardiotonics PH22999A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60059450A JPS61218589A (ja) 1985-03-26 1985-03-26 ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体

Publications (1)

Publication Number Publication Date
PH22999A true PH22999A (en) 1989-02-24

Family

ID=13113637

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33568A PH22999A (en) 1985-03-26 1986-03-24 3-cyano-5-(6-imidazo(1,2-a)pyridyl)-pyridin-2-ols useful as cardiotonics

Country Status (23)

Country Link
US (4) US4751227A (fi)
EP (1) EP0199127B1 (fi)
JP (1) JPS61218589A (fi)
KR (1) KR930005005B1 (fi)
CN (1) CN1020608C (fi)
AT (1) ATE48603T1 (fi)
AU (1) AU589410B2 (fi)
CA (1) CA1309718C (fi)
DD (2) DD283390A5 (fi)
DE (1) DE3667466D1 (fi)
DK (1) DK164788C (fi)
ES (5) ES8706146A1 (fi)
FI (1) FI86722C (fi)
GR (1) GR860720B (fi)
HU (1) HU198045B (fi)
IE (1) IE59294B1 (fi)
IL (1) IL78248A (fi)
MX (1) MX163696B (fi)
NO (1) NO163490C (fi)
PH (1) PH22999A (fi)
PT (1) PT82270B (fi)
SU (1) SU1468420A3 (fi)
ZA (1) ZA862259B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
JPH05503919A (ja) * 1989-06-13 1993-06-24 スミスクライン・ビーチャム・コーポレイション 単球および／またはマクロファージによるインターロイキン―１または腫瘍壊死因子生成の抑制
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
SE9903611D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds III
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2011074658A1 (ja) * 2009-12-18 2011-06-23 田辺三菱製薬株式会社 新規抗血小板薬
CN101830900B (zh) * 2010-05-27 2012-06-06 齐鲁制药(海南)有限公司 盐酸奥普力农晶型及其制备方法
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
CN102702197B (zh) * 2012-06-27 2014-12-03 武汉武药科技有限公司 盐酸奥普力农衍生物及其制备方法
CN102718747B (zh) * 2012-06-27 2014-06-11 武汉武药科技有限公司 盐酸奥普力农衍生物及其合成方法
CA2902348C (en) 2013-02-25 2021-11-30 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
CN106349246B (zh) * 2016-08-29 2018-10-26 山东百诺医药股份有限公司 奥普力农及9-氮杂吲哚-5-硼酸的制备方法
CN108840866A (zh) * 2018-05-24 2018-11-20 河北宇辰医药科技有限公司 一种奥普力农类似物ⅰ的制备方法与用途
CN109575017A (zh) * 2018-11-01 2019-04-05 山东蒲济医药科技有限公司 一种盐酸奥普力农化合物的制备方法
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport
CN111499631B (zh) * 2020-06-02 2021-07-30 济南康桥医药科技有限公司 一种盐酸奥普力农关键中间体1-咪唑并[1,2-a]吡啶-6-基-2-丙酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
NO861190L (no) 1986-09-29
IE59294B1 (en) 1994-02-09
CA1309718C (en) 1992-11-03
DK137786D0 (da) 1986-03-25
ES557587A0 (es) 1988-02-16
US4791203A (en) 1988-12-13
MX163696B (es) 1992-06-15
NO163490C (no) 1990-06-06
ES8801655A1 (es) 1988-02-16
HU198045B (en) 1989-07-28
IL78248A (en) 1989-09-10
AU589410B2 (en) 1989-10-12
ES557235A0 (es) 1987-10-01
ES557236A0 (es) 1987-10-01
ES557588A0 (es) 1988-02-16
IE860775L (en) 1986-09-26
DK164788B (da) 1992-08-17
KR860007257A (ko) 1986-10-10
US4803276A (en) 1989-02-07
ATE48603T1 (de) 1989-12-15
ES8706146A1 (es) 1987-05-16
DD263057A5 (de) 1988-12-21
CN86102812A (zh) 1986-11-26
DK137786A (da) 1986-09-27
DK164788C (da) 1992-12-28
JPH0558437B2 (fi) 1993-08-26
ZA862259B (en) 1986-11-26
DD283390A5 (de) 1990-10-10
FI861262A0 (fi) 1986-03-25
SU1468420A3 (ru) 1989-03-23
FI86722B (fi) 1992-06-30
DE3667466D1 (de) 1990-01-18
ES8708231A1 (es) 1987-10-01
ES8801654A1 (es) 1988-02-16
PT82270A (en) 1986-04-01
ES8708230A1 (es) 1987-10-01
PT82270B (pt) 1988-02-17
IL78248A0 (en) 1986-07-31
EP0199127B1 (en) 1989-12-13
JPS61218589A (ja) 1986-09-29
FI861262A (fi) 1986-09-27
HUT41026A (en) 1987-03-30
US4791202A (en) 1988-12-13
KR930005005B1 (ko) 1993-06-11
FI86722C (fi) 1992-10-12
GR860720B (en) 1986-03-25
US4751227A (en) 1988-06-14
CN1020608C (zh) 1993-05-12
AU5507286A (en) 1986-10-02
NO163490B (no) 1990-02-26
EP0199127A1 (en) 1986-10-29
ES553370A0 (es) 1987-05-16

Similar Documents

Publication Publication Date Title
PH22999A (en) 3-cyano-5-(6-imidazo(1,2-a)pyridyl)-pyridin-2-ols useful as cardiotonics
EP0383449A3 (en) Pyridazinone derivatives and processes for preparing the same
ZW13082A1 (en) Pyridylalkylaminopyrimidone derivatives
EP0259835A3 (en) Pyridazinone derivatives
FR2529891B1 (fi)
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi